Kazia Therapeutics said two studies about its drug paxalisib will be shown at the 2026 San Antonio Breast Cancer Symposium.

KZIA · Kazia Therapeutics

The AI's read

This gives researchers a place to present work on paxalisib, which is being studied in several cancers. The story does not say what the studies found or whether patients benefited. Without those results, the acceptance alone does not change what is known about Kazia's drug prospects.